On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
Welcome to Few & Far Between: Conversations About Rare Disease Research with your host, Chris O'Brien. Episode Zero contains everything you need to know...
With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast....
"We work with hundreds of patients a month, helping them understand their own medical history and then tracking what happens to them in the...